BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29323173)

  • 41. Genome Editing in Mouse Zygotes and Embryonic Stem Cells by Introducing SgRNA/Cas9 Expressing Plasmids.
    Noda T; Oji A; Ikawa M
    Methods Mol Biol; 2017; 1630():67-80. PubMed ID: 28643250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
    Wilbie D; Walther J; Mastrobattista E
    Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful
    Takabayashi S; Iijima K; Tsujimura M; Aoshima T; Takagi H; Aoto K; Sato M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient gene targeting in mouse zygotes mediated by CRISPR/Cas9-protein.
    Jung CJ; Zhang J; Trenchard E; Lloyd KC; West DB; Rosen B; de Jong PJ
    Transgenic Res; 2017 Apr; 26(2):263-277. PubMed ID: 27905063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Introducing gene deletions by mouse zygote electroporation of Cas12a/Cpf1.
    Dumeau CE; Monfort A; Kissling L; Swarts DC; Jinek M; Wutz A
    Transgenic Res; 2019 Dec; 28(5-6):525-535. PubMed ID: 31482512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generating Mutant Renal Cell Lines Using CRISPR Technologies.
    Perretta-Tejedor N; Freke G; Seda M; Long DA; Jenkins D
    Methods Mol Biol; 2020; 2067():323-340. PubMed ID: 31701460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
    Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
    Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transgenic Expression and Genome Editing by Electroporation of Zebrafish Embryos.
    Zhang C; Ren Z; Gong Z
    Mar Biotechnol (NY); 2020 Oct; 22(5):644-650. PubMed ID: 32748174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome Editing of Mouse by Cytoplasmic Injection.
    Horii T; Hatada I
    Methods Mol Biol; 2017; 1630():55-66. PubMed ID: 28643249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice.
    Sato M; Miyagasako R; Takabayashi S; Ohtsuka M; Hatada I; Horii T
    Cells; 2020 Feb; 9(3):. PubMed ID: 32110989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zona pellucida treatment before CRISPR/Cas9-mediated genome editing of porcine zygotes.
    Namula Z; Hirata M; Le QA; Lin Q; Takebayashi K; Yoshimura N; Tanihara F; Thongkittidilok C; Otoi T
    Vet Med Sci; 2022 Jan; 8(1):164-169. PubMed ID: 34674375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction of a point mutation in the KRAS gene of in vitro fertilized porcine zygotes via electroporation of the CRISPR/Cas9 system with single-stranded oligodeoxynucleotides.
    Wittayarat M; Hirata M; Namula Z; Sato Y; Nguyen NT; Le QA; Lin Q; Takebayashi K; Tanihara F; Otoi T
    Anim Sci J; 2021; 92(1):e13534. PubMed ID: 33638256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene Excision by Dual-Guide CRISPR-Cas9.
    Spagnuolo M; Blenner M
    Methods Mol Biol; 2021; 2307():85-94. PubMed ID: 33847983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD.
    Gurumurthy CB; Sato M; Nakamura A; Inui M; Kawano N; Islam MA; Ogiwara S; Takabayashi S; Matsuyama M; Nakagawa S; Miura H; Ohtsuka M
    Nat Protoc; 2019 Aug; 14(8):2452-2482. PubMed ID: 31341289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of Mouse Model (KI and CKO) via Easi-CRISPR.
    Shola DTN; Yang C; Han C; Norinsky R; Peraza RD
    Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.